Powerful Chinese Government Commission Set To Issue Price Caps For Essential Drug List Medicines
This article was originally published in PharmAsia News
Executive Summary
BEIJING - China's powerful National Development and Reform Commission, which has a virtually unrestricted purview over setting prices for medicines that are included on the country's Essential Drug List, is in the final stages of determining caps for every item on the newly revised list
You may also be interested in...
China's Essential Drug Prices Less Severe Than Expected; Some Prices See Increases
SHANGHAI - China's National Development and Reform Commission issued Oct. 2 a guideline price for its Essential Drug List, which stipulates price ceilings for 296 drugs on the first part of the list
China's Essential Drug Prices Less Severe Than Expected; Some Prices See Increases
SHANGHAI - China's National Development and Reform Commission issued Oct. 2 a guideline price for its Essential Drug List, which stipulates price ceilings for 296 drugs on the first part of the list
China's Essential Drug Prices Less Severe Than Expected; Some Prices See Increases
Prices for half of the drug products on the list will stay at current levels.